{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T21:43:43Z","timestamp":1778708623356,"version":"3.51.4"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s00259-025-07558-8","type":"journal-article","created":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T07:11:50Z","timestamp":1757747510000},"page":"1620-1627","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Detection rate of FDG-PET\/CT for occult cancer in patients with cryptogenic ischemic stroke"],"prefix":"10.1007","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1273-0396","authenticated-orcid":false,"given":"Carmen","family":"Garc\u00eda-Cabo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"Benavente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"del Amor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Vigil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sara Naranjo","family":"Sancho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Rico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Montserrat","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davinia","family":"Larrosa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Casta\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"L\u00f3pez-Cancio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma Gonz\u00e1lez","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Calleja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,9,13]]},"reference":[{"issue":"1","key":"7558_CR1","volume":"2","author":"JL Dearborn","year":"2014","unstructured":"Dearborn JL, Urrutia VC, Zeiler SR. Stroke and cancer- a complicated relationship. J Neurol Transl Neurosci. 2014;2(1):1039.","journal-title":"J Neurol Transl Neurosci"},{"key":"7558_CR2","doi-asserted-by":"publisher","first-page":"E104","DOI":"10.5888\/pcd12.140482","volume":"12","author":"HK Weir","year":"2015","unstructured":"Weir HK, Thompson TD, Soman A, et al. Meeting the healthy people 2020 objectives to reduce cancer mortality. Prev Chronic Dis. 2015;12:E104.","journal-title":"Prev Chronic Dis"},{"issue":"10","key":"7558_CR3","doi-asserted-by":"publisher","first-page":"e146","DOI":"10.1161\/CIR.0000000000000485","volume":"135","author":"EJ Benjamin","year":"2017","unstructured":"Benjamin EJ, Blaha MJ, Chiuve SE, American Heart Association Statistics Committee and Stroke Statistics Subcommittee, et al. Heart disease and stroke Statistics-2017 update: A report from the American heart association. Circulation. 2017;135(10):e146\u2013603.","journal-title":"Circulation"},{"issue":"2","key":"7558_CR4","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11060-009-9818-3","volume":"94","author":"O Stefan","year":"2009","unstructured":"Stefan O, Vera N, Otto B, et al. Stroke in cancer patients: a risk factor analysis. J Neurooncol. 2009;94(2):221\u20136.","journal-title":"J Neurooncol"},{"issue":"5","key":"7558_CR5","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.07.041","volume":"23","author":"HA Selvik","year":"2014","unstructured":"Selvik HA, Thomassen L, Logallo N. Prior cancer in patients with ischemic stroke: the Bergen NORSTROKE study. J Stroke Cerebrovasc Dis. 2014;23(5):919\u201325.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"3","key":"7558_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000440730","volume":"5","author":"HA Selvik","year":"2015","unstructured":"Selvik HA, Thomassen L, Bjerkreim AT, et al. Cancer-associated stroke: the Bergen NORSTROKE study. Cerebrovasc Dis Extra. 2015;5(3):107\u201313.","journal-title":"Cerebrovasc Dis Extra"},{"issue":"4","key":"7558_CR7","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1161\/STROKEAHA.109.571356","volume":"41","author":"SG Kim","year":"2010","unstructured":"Kim SG, Hong JM, Kim HY, et al. Ischemic stroke in cancer patients with and without conventional mechanisms: a multicenter study in Korea. Stroke. 2010;41(4):798\u2013801.","journal-title":"Stroke"},{"key":"7558_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2020.103181","volume":"157","author":"RA Salazar-Camelo","year":"2021","unstructured":"Salazar-Camelo RA, Moreno-Vargas EA, Cardona AF, et al. Ischemic stroke: a paradoxical manifestation of cancer. Crit Rev Oncol Hematol. 2021;157:103181.","journal-title":"Crit Rev Oncol Hematol"},{"key":"7558_CR9","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.thromres.2018.03.011","volume":"165","author":"S Grazioli","year":"2018","unstructured":"Grazioli S, Paciaroni M, Agnelli G, et al. Cancer-associated ischemic stroke: a retrospective multicentre cohort study. Thromb Res. 2018;165:33\u20137.","journal-title":"Thromb Res"},{"issue":"1\u20132","key":"7558_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1159\/000484668","volume":"45","author":"HA Selvik","year":"2018","unstructured":"Selvik HA, Bjerkreim AT, Thomassen L, et al. When to screen ischaemic stroke patients for cancer. Cerebrovasc Dis. 2018;45(1\u20132):42\u20137.","journal-title":"Cerebrovasc Dis"},{"issue":"4","key":"7558_CR11","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.jstrokecerebrovasdis.2013.10.022","volume":"23","author":"YJ Guo","year":"2014","unstructured":"Guo YJ, Chang MH, Chen PL, et al. Predictive value of plasma d-dimer levels for cancer-related stroke: a 3-year retrospective study. J Stroke Cerebrovasc Dis. 2014;23(4):249\u201354.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"4","key":"7558_CR12","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1159\/000235629","volume":"28","author":"C-T Hong","year":"2009","unstructured":"Hong C-T, Tsai L-K, Jeng J-S. Patterns of acute cerebral infarcts in patients with active malignancy using diffusion-weighted imaging. Cerebrovasc Dis. 2009;28(4):411\u20136.","journal-title":"Cerebrovasc Dis"},{"issue":"8","key":"7558_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2022.106609","volume":"31","author":"M Beyeler","year":"2022","unstructured":"Beyeler M, Birner B, Branca M, et al. Development of a score for prediction of occult malignancy in stroke patients (occult-5 score). J Stroke Cerebrovasc Dis. 2022;31(8):106609.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"Suppl 1","key":"7558_CR14","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1016\/j.thromres.2022.01.018","volume":"213","author":"A Delluc","year":"2022","unstructured":"Delluc A, Robin P. 18F-fluorodeoxyglucose positron emission\/computed tomography for occult cancer among patients with unprovoked venous thromboembolism: what do we know? Thromb Res. 2022;213(Suppl 1):S42-5.","journal-title":"Thromb Res"},{"key":"7558_CR15","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.thromres.2018.09.050","volume":"171","author":"P Robin","year":"2018","unstructured":"Robin P, Kumar S, Salaun PY, et al. In patients with unprovoked VTE, does the addition of FDG PET\/CT to a limited occult cancer screening strategy offer good value for money? A cost-effectiveness analysis from the publicly funded health care systems. Thromb Res. 2018;171:97\u2013102.","journal-title":"Thromb Res"},{"key":"7558_CR16","doi-asserted-by":"crossref","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, Brown M, Demaerschalk BM, Hoh B, Jauch EC, Kidwell CS, Leslie-Mazwi TM, Ovbiagele B, Scott PA, Sheth KN, Southerland AM, Summers DV, Tirschwell DL. Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American heart association\/American stroke association. Stroke. 2019;50(12):e344\u2013e418.","DOI":"10.1161\/STR.0000000000000211"},{"issue":"1","key":"7558_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, et al. 3rd. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of org 10172 in acute stroke treatment. Stroke. 1993;24(1):35\u201341.","journal-title":"Stroke"},{"key":"7558_CR18","doi-asserted-by":"crossref","unstructured":"Boellaard R, Delgado-Bolton R, Oyen WJ, Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF, Pike LC, Weber WA, Stroobants S, Delbeke D, Donohoe KJ, Holbrook S, Graham MM, Testanera G, Hoekstra OS, Zijlstra J, Visser E, Hoekstra CJ, Pruim J, Willemsen A, Arends B, Kotzerke J, Bockisch A, Beyer T, Chiti A, Krause BJ. European Association of Nuclear Medicine (EANM). FDG PET\/CT: EANM procedure guidelines for tumour imaging: version 2.0. Eur J Nucl Med Mol Imaging. 2015;42(2):328\u201354.","DOI":"10.1007\/s00259-014-2961-x"},{"issue":"4","key":"7558_CR19","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","volume":"48","author":"RG Hart","year":"2017","unstructured":"Hart RG, Catanese L, Perera KS, et al. Embolic stroke of undetermined source: a systematic review and clinical update. Stroke. 2017;48(4):867\u201372.","journal-title":"Stroke"},{"issue":"2","key":"7558_CR20","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1212\/CON.0000000000000832","volume":"26","author":"H Kamel","year":"2020","unstructured":"Kamel H. The evolving concept of cryptogenic stroke. Continuum. 2020;26(2):353\u201362.","journal-title":"Continuum"},{"issue":"4","key":"7558_CR21","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1161\/STROKEAHA.117.020031","volume":"49","author":"R Ornello","year":"2018","unstructured":"Ornello R, Degan D, Tiseo C, et al. Distribution and temporal trends from 1993 to 2015 of ischemic stroke subtypes: a systematic review and meta-analysis. Stroke. 2018;49(4):814\u20139.","journal-title":"Stroke"},{"issue":"2","key":"7558_CR22","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1212\/CPJ.0000000000000603","volume":"9","author":"AM Nouh","year":"2019","unstructured":"Nouh AM, Staff I, Finelli PF. Three territory sign: an MRI marker of malignancy-related ischemic stroke (Trousseau syndrome). Neurol Clin Pract. 2019;9(2):124\u20138.","journal-title":"Neurol Clin Pract"},{"issue":"7","key":"7558_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.104823","volume":"29","author":"L Guo","year":"2020","unstructured":"Guo L, Wang L, Liu W. Ability of the number of territories involved on DWI-MRI to predict occult systemic malignancy in cryptogenic stroke patients. J Stroke Cerebrovasc Dis. 2020;29(7):104823.","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"7558_CR24","doi-asserted-by":"crossref","unstructured":"Erritz\u00f8e-Jervild M, Wenstrup J, Hougaard BH, Kruuse C. Diagnosing cancer-associated ischemic stroke: a systematic review of hematological biomarkers. Int J Stroke. 2024;19(6):622\u2013634.","DOI":"10.1177\/17474930241227385"},{"issue":"12","key":"7558_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/j.jstrokecerebrovasdis.2020.105366","volume":"29","author":"J Rosenberg","year":"2020","unstructured":"Rosenberg J, Do D, Cucchiara B, et al. D-dimer and body CT to identify occult malignancy in acute ischemic stroke. J Stroke Cerebrovasc Dis. 2020;29(12):105366.","journal-title":"J Stroke Cerebrovasc Dis"},{"issue":"10","key":"7558_CR26","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.2967\/jnumed.109.065151","volume":"50","author":"A Rominger","year":"2009","unstructured":"Rominger A, Saam T, Wolpers S, et al. 18F-FDG PET\/CT identifies patients at risk for future vascular events in an otherwise asymptomatic cohort with neoplastic disease. J Nucl Med. 2009;50(10):1611\u201320.","journal-title":"J Nucl Med"},{"issue":"8","key":"7558_CR27","first-page":"1369","volume":"41","author":"T Beyer","year":"2000","unstructured":"Beyer T, Townsend DW, Brun T, et al. A combined PET\/CT scanner for clinical oncology. J Nucl Med. 2000;41(8):1369\u201379.","journal-title":"J Nucl Med"},{"issue":"6","key":"7558_CR28","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s10147-014-0666-6","volume":"19","author":"T Sengoku","year":"2014","unstructured":"Sengoku T, Matsumura K, Usami M, et al. Diagnostic accuracy of FDG-PET cancer screening in asymptomatic individuals: use of record linkage from the Osaka cancer registry. Int J Clin Oncol. 2014;19(6):989\u201397.","journal-title":"Int J Clin Oncol"},{"issue":"12","key":"7558_CR29","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1054\/bjoc.2000.1496","volume":"83","author":"S Yasuda","year":"2000","unstructured":"Yasuda S, Ide M, Fujii H, et al. Application of positron emission tomography imaging to cancer screening. Br J Cancer. 2000;83(12):1607\u201311.","journal-title":"Br J Cancer"},{"key":"7558_CR30","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0140-6736(97)24051-1","volume":"350","author":"S Yasuda","year":"1997","unstructured":"Yasuda S, Shohtsu A. Cancer screening with whole- body 18F-fluorodeoxyglucose positron-emission tomography. Lancet. 1997;350:1819.","journal-title":"Lancet"},{"issue":"44","key":"7558_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000005131","volume":"95","author":"C Hu","year":"2016","unstructured":"Hu C, Liu CP, Cheng JS, et al. Application of whole-body FDG-PET for cancer screening in a cohort of hospital employees. Medicine. 2016;95(44):e5131.","journal-title":"Medicine"},{"key":"7558_CR32","unstructured":"Ide M. Cancer screening with FDG-PET. Q J Nucl Med Mol Imaging. 2006;50(1):23\u20137."},{"issue":"9","key":"7558_CR33","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/s12149-011-0511-1","volume":"25","author":"T Murano","year":"2011","unstructured":"Murano T, Minamimoto R, Senda M, et al. Radiation exposure and risk-benefit analysis in cancer screening using FDG-PET: results of a Japanese nationwide survey. Ann Nucl Med. 2011;25(9):657\u201366.","journal-title":"Ann Nucl Med"},{"issue":"7","key":"7558_CR34","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/S1470-2045(21)00199-6","volume":"22","author":"R Cardoso","year":"2021","unstructured":"Cardoso R, Guo F, Heisser T, et al. Colorectal cancer incidence, mortality, and stage distribution in European countries in the colorectal cancer screening era: an international population-based study. Lancet Oncol. 2021;22(7):1002\u201313.","journal-title":"Lancet Oncol"},{"issue":"2","key":"7558_CR35","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/ana.24325","volume":"77","author":"BB Navi","year":"2015","unstructured":"Navi BB, Reiner AS, Kamel H, et al. Association between incident cancer and subsequent stroke. Ann Neurol. 2015;77(2):291\u2013300.","journal-title":"Ann Neurol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00259-025-07558-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-025-07558-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,31]],"date-time":"2026-01-31T04:43:01Z","timestamp":1769834581000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00259-025-07558-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,13]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["7558"],"URL":"https:\/\/doi.org\/10.1007\/s00259-025-07558-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,13]]},"assertion":[{"value":"5 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research was conducted ethically in accordance with the\u00a0Declaration of Helsinki ethical principles for medical research involving human. All subjects have given their written informed consent and the study protocol was reviewed and approved by Hospital Universitario Central de Asturias Ethics Committee, approval number 2021.174.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Statement of ethics"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no conflicts of interest to declare.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}